SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-13-083703
Filing Date
2013-11-12
Accepted
2013-11-12 17:08:27
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a13-18860_110q.htm 10-Q 876035
2 EX-31.1 a13-18860_1ex31d1.htm EX-31.1 10140
3 EX-31.2 a13-18860_1ex31d2.htm EX-31.2 10056
4 EX-32.1 a13-18860_1ex32d1.htm EX-32.1 4208
5 EX-32.2 a13-18860_1ex32d2.htm EX-32.2 4511
  Complete submission text file 0001104659-13-083703.txt   5245866

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT stml-20130930.xml EX-101.INS 627352
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT stml-20130930.xsd EX-101.SCH 39635
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT stml-20130930_cal.xml EX-101.CAL 36279
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT stml-20130930_def.xml EX-101.DEF 156940
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT stml-20130930_lab.xml EX-101.LAB 658908
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT stml-20130930_pre.xml EX-101.PRE 291011
Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address 750 LEXINGTON AVENUE NEW YORK NY 10022 212-831-1111
STEMLINE THERAPEUTICS INC (Filer) CIK: 0001264587 (see all company filings)

IRS No.: 450522567 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35619 | Film No.: 131211261
SIC: 2834 Pharmaceutical Preparations